Evidence map›Paper›PMID 38236633›Full record

ArticleeLife2024

Illuminating T cell-dendritic cell interactions in vivo by FlAsHing antigens.

Munir Akkaya, Jafar Al Souz, Daniel Williams, Rahul Kamdar, Olena Kamenyeva, Juraj Kabat, Ethan Shevach, Billur Akkaya

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Munir Akkaya *Department of Internal Medicine, Division of Rheumatology and Immunology, The College of Medicine, The Ohio State University, Columbus, United States.
Jafar Al Souz *National Institute of Allergy and Infectious Diseases, Bethesda, United States.
Daniel WilliamsNational Institute of Allergy and Infectious Diseases, Bethesda, United States.
Rahul KamdarNational Institute of Allergy and Infectious Diseases, Bethesda, United States.
Olena KamenyevaNational Institute of Allergy and Infectious Diseases, Bethesda, United States.ORCID https://orcid.org/0000-0002-6541-5616
Juraj KabatNational Institute of Allergy and Infectious Diseases, Bethesda, United States.
Ethan ShevachNational Institute of Allergy and Infectious Diseases, Bethesda, United States.
Billur AkkayaPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, United States.ORCID https://orcid.org/0000-0002-6808-3776
National Institute of Allergy and Infectious Diseases · USThe Ohio State University Wexner Medical Center · US

Funding

Infectious Diseases Research Technologies Core - BethesdaZICAI001051 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHERRY, JAMES · 2009 to 2025
$226.1M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Studies of the Function of Naturally Occurring and Adaptive T Regulatory CellsZIAAI000959 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHEVACH, ETHAN · 2009 to 2025
$17.6M
Control of Autoimmunity by Regulatory T CellsZIAAI000224 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHEVACH, ETHAN · 2009 to 2025
$13.4M
Deciphering the specificity and molecular mechanisms of regulatory T cells using novel approachesDP2AI154451 · NIAID · OHIO STATE UNIVERSITY · PI Billur Akkaya · 2022 to 2026
$2.3M
Intramural NIH HHS ZIA AI000224NCI NIH HHS P30 CA016058NIAID NIH HHS DP2 AI154451
6 · The paper itself

Abstract

Delineating the complex network of interactions between antigen-specific T cells and antigen presenting cells (APCs) is crucial for effective precision therapies against cancer, chronic infections, and autoimmunity. However, the existing arsenal for examining antigen-specific T cell interactions is restricted to a select few antigen-T cell receptor pairs, with limited in situ utility. This lack of versatility is largely due to the disruptive effects of reagents on the immune synapse, which hinder real-time monitoring of antigen-specific interactions. To address this limitation, we have developed a novel and versatile immune monitoring strategy by adding a short cysteine-rich tag to antigenic peptides that emits fluorescence upon binding to thiol-reactive biarsenical hairpin compounds. Our findings demonstrate the specificity and durability of the novel antigen-targeting probes during dynamic immune monitoring in vitro and in vivo. This strategy opens new avenues for biological validation of T-cell receptors with newly identified epitopes by revealing the behavior of previously unrecognized antigen-receptor pairs, expanding our understanding of T cell responses.

Indexed as

Antigen-Presenting CellsAutoimmunityCell CommunicationCysteineEpitopesCysteineEpitopesantigendendritic cellimmune responseimmune synapseimmunologyinflammationmouset cell

Identifiers

PMID38236633
PMCPMC10945603
OpenAlexW4388290062

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.